Susan A. Slaugenhaupt, PhD, is exploring how her research on familial dysautonomia, a rare disease, might provide important insights about other disorders.
Basic science and creative research benefit from the MGH Research Scholars Program, says Jack Szostak, PhD, a renowned MGH scientist and Nobel Laureate.
Raul Mostoslavsky, MD, PhD, and his Mass General team have identified a protein that puts the brakes on cancer cell growth by regulating certain genes.
Sekar Kathiresan, MD, is determined to better understand the genes linked to heart attacks and how they contribute to the development of heart disease.
Mass General researchers have created a new generation of brain mapping images that promises to open the door to understanding and treating brain disorders.
With the goal of detecting and treating Alzheimer’s disease before symptoms appear, researchers at Mass General have teamed up with an army of volunteers.
Mass General is pioneering the wider use of a heart-lung technology called ECMO to treat pulmonary embolisms and other life-threatening conditions.
At Mass General researchers are looking to immunotherapy, recently hailed as Science Magazine’s “Breakthrough of the Year,” as the next step in the fight against cancer.
Mass General is using a new treatment called TMS to help regulate nerve cells involved in mood regulation that may be underactive in depression.
A young woman gets a medication-free kidney transplant after MGH doctors transplanted bone marrow to make her immune system think the new organ was her own.